Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Meet-the-CML-Experts Q&A Session: TKI toxicities + dose optimisation

Collage HughesLipton

Panel of experts:

Professor Timothy Hughes
SAHMRI/University of Adelaide/
Royal Hospital of Adelaide (Australia)

Professor Jeff Lipton
University of Toronto (Canada)

iCMLf Conversation: Genomics and Mutations in CML

  susan branford

Expert:

Professor Susan Branford
Head, Leukemia Unit, Genetis and Molecular Pathology, SA Pathology, Adelaide (Australia)

iCMLf Conversation: Management of advanced phases of CML

  Mhairi Copland

Expert:

Professor Mhairi Copland
Professor of Translational Haematology
University of Glasgow
(UK)

iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview

Michael Mauro

Expert:

Professor Michael Mauro
Leader of the Myeloproliferative Neoplams Program at the Memorial Sloan Kettering Cancer Centre / Professor of Clinical Medicine at the Weill Cornell Medical College, New York (USA)

iCMLf Conversation: CML Highlights of ASH 2022 - Biological overview

Ravi Bhatia

Expert:

Professor Ravi Bhatia
Director of the Stem Cell Program at the University of Alabama in Birmingham (USA)